X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with ALEMBIC LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs ALEMBIC LTD - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD ALEMBIC LTD BIOCON LTD/
ALEMBIC LTD
 
P/E (TTM) x 36.6 76.1 48.1% View Chart
P/BV x 4.9 2.8 172.0% View Chart
Dividend Yield % 1.5 0.4 383.2%  

Financials

 BIOCON LTD   ALEMBIC LTD
EQUITY SHARE DATA
    BIOCON LTD
Mar-16
ALEMBIC LTD
Mar-16
BIOCON LTD/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs49653 938.8%   
Low Rs39729 1,353.2%   
Sales per share (Unadj.) Rs174.34.7 3,692.4%  
Earnings per share (Unadj.) Rs44.88.8 510.7%  
Cash flow per share (Unadj.) Rs56.99.0 632.2%  
Dividends per share (Unadj.) Rs5.000.15 3,333.3%  
Dividend yield (eoy) %1.10.4 306.7%  
Book value per share (Unadj.) Rs202.827.7 731.3%  
Shares outstanding (eoy) m200.00267.03 74.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.68.7 29.4%   
Avg P/E ratio x10.04.7 212.8%  
P/CF ratio (eoy) x7.84.6 171.9%  
Price / Book Value ratio x2.21.5 148.6%  
Dividend payout %11.21.7 652.7%   
Avg Mkt Cap Rs m89,22010,962 813.9%   
No. of employees `0004.4NA-   
Total wages/salary Rs m6,363238 2,673.5%   
Avg. sales/employee Rs Th7,894.5NM-  
Avg. wages/employee Rs Th1,441.2NM-  
Avg. net profit/employee Rs Th2,029.7NM-  
INCOME DATA
Net Sales Rs m34,8541,260 2,765.5%  
Other income Rs m845264 320.3%   
Total revenues Rs m35,6991,524 2,342.3%   
Gross profit Rs m8,20083 9,903.4%  
Depreciation Rs m2,42361 3,946.3%   
Interest Rs m1020 34,000.0%   
Profit before tax Rs m6,520285 2,288.5%   
Minority Interest Rs m-7440-   
Prior Period Items Rs m02,096 0.0%   
Extraordinary Inc (Exp) Rs m5,754-32 -17,869.6%   
Tax Rs m2,5696 42,114.8%   
Profit after tax Rs m8,9612,343 382.5%  
Gross profit margin %23.56.6 358.1%  
Effective tax rate %39.42.1 1,840.3%   
Net profit margin %25.7185.9 13.8%  
BALANCE SHEET DATA
Current assets Rs m39,9321,689 2,364.5%   
Current liabilities Rs m16,276486 3,347.6%   
Net working cap to sales %67.995.4 71.1%  
Current ratio x2.53.5 70.6%  
Inventory Days Days54217 24.7%  
Debtors Days Days8681 106.3%  
Net fixed assets Rs m39,1011,624 2,407.5%   
Share capital Rs m1,000534 187.2%   
"Free" reserves Rs m38,5915,960 647.5%   
Net worth Rs m40,5567,404 547.8%   
Long term debt Rs m20,724104 19,869.6%   
Total assets Rs m84,8168,010 1,058.8%  
Interest coverage x64.9950.7 6.8%   
Debt to equity ratio x0.50 3,627.4%  
Sales to assets ratio x0.40.2 261.2%   
Return on assets %10.729.3 36.5%  
Return on equity %22.131.6 69.8%  
Return on capital %19.031.3 60.7%  
Exports to sales %30.72.9 1,044.5%   
Imports to sales %20.428.9 70.6%   
Exports (fob) Rs m10,71737 28,886.8%   
Imports (cif) Rs m7,105364 1,953.6%   
Fx inflow Rs m11,78937 31,776.3%   
Fx outflow Rs m8,393365 2,299.8%   
Net fx Rs m3,396-328 -1,035.9%   
CASH FLOW
From Operations Rs m5,264346 1,523.1%  
From Investments Rs m-9,540-48 20,042.0%  
From Financial Activity Rs m10,867-301 -3,610.3%  
Net Cashflow Rs m6,591-3 -219,700.0%  

Share Holding

Indian Promoters % 40.4 64.0 63.1%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 0.2 4,200.0%  
FIIs % 10.7 9.7 110.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 26.1 76.2%  
Shareholders   109,995 54,701 201.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   CADILA HEALTHCARE  TTK HEALTHCARE  ORCHID PHARMA LTD  STRIDES SHASUN LTD  J.B.CHEMICALS  

Compare BIOCON LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Pharma Drug Approvals, Global Updates, Oil Prices, and Top Stocks in Action Today(Pre-Open)

Indian share markets snapped their losing streak seen during last week and closed their Wednesday session on a positive note.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Aug 16, 2017 (Close)

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE BIOCON LTD WITH

MARKET STATS